Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response (2008)
- Authors:
- USP affiliated authors: HIRATA, MARIO HIROYUKI - FCF ; DOREA, EGIDIO LIMA - HU ; BERNIK, MARCIA MARTINS SILVEIRA - HU ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF
- Unidades: FCF; HU
- DOI: 10.1016/j.cca.2008.03.031
- Subjects: EXPRESSÃO GÊNICA; FARMACOGENÉTICA
- Language: Inglês
- Imprenta:
- Source:
- Título: Clinica Chimica Acta
- ISSN: 0009-8981
- Volume/Número/Paginação/Ano: v. 393, n. 2, p. 119-124, 2008
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
ARAZI, Simone Sorkin et al. Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response. Clinica Chimica Acta, v. 393, n. 2, p. 119-124, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.cca.2008.03.031. Acesso em: 29 dez. 2025. -
APA
Arazi, S. S., Genvigir, F. D. V., Willrich, M. A. V., Hirata, M. H., Dorea, E. L., Bernik, M. M. S., & Hirata, R. D. C. (2008). Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response. Clinica Chimica Acta, 393( 2), 119-124. doi:10.1016/j.cca.2008.03.031 -
NLM
Arazi SS, Genvigir FDV, Willrich MAV, Hirata MH, Dorea EL, Bernik MMS, Hirata RDC. Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response [Internet]. Clinica Chimica Acta. 2008 ; 393( 2): 119-124.[citado 2025 dez. 29 ] Available from: https://doi.org/10.1016/j.cca.2008.03.031 -
Vancouver
Arazi SS, Genvigir FDV, Willrich MAV, Hirata MH, Dorea EL, Bernik MMS, Hirata RDC. Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response [Internet]. Clinica Chimica Acta. 2008 ; 393( 2): 119-124.[citado 2025 dez. 29 ] Available from: https://doi.org/10.1016/j.cca.2008.03.031 - CYP3A5 polymorphism is associated with differences on gene expression and cholesterol-lowering response to atorvastatin
- Atorvastatin down-regulates ABCA1 gene expression in peripheral blood mononuclear cells of Brazilian hyper-cholesterolemic patients
- Atorvastatin effects on SREBF1 and SCAP gene expression in peripheral blood mononuclear cells of hypercholesterolemic patients
- Study of the variant of the leptin receptor (Lys109arg) and possible association with obesity and the development of diabetes
- Polimorfismos no receptor scavenger classe B tipo I e sua relação com perfil sérico e resposta a atorvastatina em indivíduos brasileiros
- Alteration of the expression of efflux and uptake transporters during hypercholesterolemia. Role in variability of atorvastatin response
- Estudo da expressão gênica e polimorfismos da CYP3A5 em indivíduos hipercolesterolêmicos tratados com atorvastatina
- Variants in S1P and ABCG1 genes are novel independent risk factors for dyslipidemia
- Scavenger receptor class B type I polymorphisms and its relation with serum lipids profile and response to atorvastatin in Brazilian individuals
- mRNA expression of SREBF1, SREBF2 and SCAP transcription factors in peripheral mononuclear cells is modulated by atorvastatin therapy
Informações sobre o DOI: 10.1016/j.cca.2008.03.031 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
